Effect of oral pilocarpine in treating severe dry eye in patients with sjogren syndrome

Asia-Pacific Journal of Ophthalmology

Volumn 4, Issue 2, 2015, Pages 101-105

  Kawakita, Tetsuya ^a   Shimmura, Shigeto ^a   Tsubota, Kazuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Dry eye; Oral administration; Pilocarpine; Sjogren syndrome

Indexed keywords

EYE DROPS; FLUORESCEIN; MUSCARINIC AGENT; PILOCARPINE;

ADULT; AGED; COMPLICATION; DRY EYE SYNDROMES; FEMALE; HUMAN; LACRIMAL FLUID; MALE; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY; SJOEGREN SYNDROME;

ADMINISTRATION, ORAL; ADULT; AGED; DRY EYE SYNDROMES; FEMALE; FLUORESCEIN; HUMANS; MALE; MIDDLE AGED; MUSCARINIC AGONISTS; OPHTHALMIC SOLUTIONS; PILOCARPINE; PROSPECTIVE STUDIES; SJOGREN'S SYNDROME; TEARS;

EID: 84991248742     PISSN: None     EISSN: 21620989     Source Type: Journal    
DOI: 10.1097/APO.0000000000000040     Document Type: Article

References (12)

1. Lemp MA, Baudouin C, Baum J, et al. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5:75-92.
2. Wynn RL. Oral pilocarpine (Salagen)Va recently approved salivary stimulant. Gen Dent. 1996;44:26, 29-30.
3. Tsifetaki N, Kitsos G, Paschides CA, et al. Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study. Ann Rheum Dis. 2003;62:1204-1207.
4. Papas AS, Sherrer YS, Charney M, et al. Successful treatment of dry mouth and dry eye symptoms in Sjögren's syndrome patients with oral pilocarpine: a randomized, placebo-controlled, dose-adjustment study. J Clin Rheumatol. 2004;10:169-177.
5. Aragona P, Di Pietro R, Spinella R, et al. Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndrome. Br J Ophthalmol. 2006;90:166-170.
6. Kumar A, Singla V, Khokhar S, et al. Efficacy of oral pilocarpine in patients with Sjögren's syndrome. Indian J Rheumatol. 2006;1:93-98.
7. Kono T, Shiraishi A, Yamaguchi M, et al. Effect of peroral pilocarpine for dry eye. Jpn J Clin Ophthalmol. 2011;65:617-620.
8. Miyamoto T, Eguchi H, Mitamura Y. Ocular findings following discontinuation of oral pilocarpine in patients with dry eye. Jpn J Clin Ophthalmol. 2012;66:67-71.
9. Uchino Y, Uchino M, Dogru M, et al. Changes in dry eye diagnostic status following implementation of revised Japanese dry eye diagnostic criteria. Jpn J Ophthalmol. 2012;56:8-13.
10. Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs. 1988;14:9-17.
11. Konno A, Nishio M, Origasa H. Oral Pilocarpine for Radiation-induced XerostomiaVa randomized, double-blind, placebo-controlled trial. Jpn Pharmacol Ther. 2007;35:131-140.
12. Sugai S, Koike T, Miyasaka N, et al. Dose-finding study of oral pilocarpine for the treatment of xerostomia associated with Sjögren's Syndrome. Jpn Pharmacol Ther. 2007;35:141-153.